WHO ICTRP trial
Evaluation of safety, tolerability of Septilin Syrup in healthy people.
CTRI/2022/04/041811 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2022/04/041811 |
|---|---|
| Public title | Evaluation of safety, tolerability of Septilin Syrup in healthy people. |
| Scientific title | "Safety, tolerability and sensory evaluation of Septilin Syrup in Healthy Volunteers" |
| Primary sponsor | Himalaya Wellness Company |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | India |
| Registration date | Dec 4, 2022 |
| Target size | 24 |
| Secondary IDs | HWC/MSCD/PP/050/2021, Version Number:1.0; Date: 21FEB2022 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: